We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer Broadens Gene Therapy Portfolio With $4 Billion AskBio Purchase
Bayer Broadens Gene Therapy Portfolio With $4 Billion AskBio Purchase
Bayer will pay up to $4 billion to acquire North Carolina-based gene therapy company Asklepios BioPharmaceutical (AskBio) in a move that will extend the German pharma giant’s reach into regenerative therapies.